Showing results (171-180 of 182) with videos related to
Sort By:
Pageof 19
EMBO Molecular Medicine|January 4, 2024
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancerRuina Luan, Mingcong He, Hao Li, et al.Cell Death & Disease|March 11, 2023
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinomaKai Zeng, Weiwen Xie, Chunyu Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|March 4, 2026
NMI promotes the secretion of IL-17 and exacerbates psoriasisYaqi Gao, Jingjing Wang, Zhen Qin, et al.Cancer Management and Research|April 3, 2019
A multicenter study of a contrast-enhanced ultrasound diagnostic classification of breast lesionsLina Tang, Yijie Chen, Zhongshi Du, et al.Annals of Translational Medicine|January 14, 2020
Factors influencing the performance of a diagnostic model including contrast-enhanced ultrasound in 1023 breast lesions: comparison with histopathologyYijie Chen, Lina Tang, Zhongshi Du, et al.Cell Death and Differentiation|June 5, 2020
USP22 positively modulates ERα action via its deubiquitinase activity in breast cancerShengli Wang, Xinping Zhong, Chunyu Wang, et al.Journal of Medical Virology|January 6, 2023
A vaccine delivery system promotes strong immune responses against SARS-CoV-2 variantsZhiwei Lei, Leqing Zhu, Pan Pan, et al.Cell Death & Disease|July 9, 2024
IL-27 disturbs lipid metabolism and restrains mitochondrial activity to inhibit γδ T17 cell-mediated skin inflammationMingyue Zhang, Dehai Li, Jing Zhu, et al.Cell Death & Disease|April 16, 2022
RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progressionTingting Zhou, Shengli Wang, Xiaoyu Song, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 21, 2017
RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancerShengli Wang, Hao Luo, Chunyu Wang, et al.Pageof 19